Skip to main content

Animations

MJFF Publications

3081 - 3090 of 6452 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2023
  • 2023
  • 2023
  • 2023
  • 2025
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Structural basis of polyamine transport by human ATP13A2 (PARK9)
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017
    Citation Count: 49
  • Summary Details
    OPEN
    Title: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.754016
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00241-3
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-023-01433-w
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-023-01440-x
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1280218
    Citation Count: 9
  • Summary Details
    OPEN
    Title: hipFG: high-throughput harmonization and integration pipeline for functional genomics data
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btad673
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Conducting Polymer Microelectrode Arrays for Simultaneous Electrophysiology and Advanced Brain Imaging
    Journal Name: Advanced Functional Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/adfm.202417312
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2302720120
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson’s disease-linked LRRK2 kinase
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.87098
    Citation Count: 73
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.